Emerging Infectious Disease and Transfusion Medicine: Time
to take Action with Proactive Measures
Ángel Luis Pajares Herraiz*
DOI: 10.26717/BJSTR.2017.01.000167
-
Author Information
Open or Close
- Centro Regional de Transfusión Toledo-Guadalajara & Servicio de Transfusión Complejo Hospitalario de Toledo, Spain
*Corresponding author:
Ángel Luis Pajares Herraiz, Director Centro Regional de Transfusión Toledo-Guadalajara & Servicio de Transfusión Complejo
Hospitalario de Toledo, Avenida Barber 30, TOLEDO, España
Received: June 27, 2017 Published: July 03, 2017
To view the Full Article Peer-reviewed Article PDF
Abstract
One of the concerns throughout the history of transfusion
medicine has been the transmission of infectious diseases through
the transfusion of allogeneic blood. Since the identification of
post transfusion hepatitis in the 1940s [1], the AIDS epidemic in
the 1980s [2], the discovery of hepatitis C in 1989 and its role in
blood donation and transmission of HCV [3], and most recently
-between 1980 and 1996 the delivery of the variant of Creutzfeldt-
Jakob disease by blood transfusion [4,5], transfusion medicine had
to implement stronger and more secure measures in the selection
of blood donors and in the diagnosis of Transfusion-transmissible
diseases (TTD) in order to avoid post-transfusion transmission of
infectious agents, mainly HBV, HCV and VIH.
Opinion |
Conclusion |
References |
ISSN: 2574 -1241
